The M.O.R.E. Institute is a solid structure made of people and services providing continuous and effective top-level education worldwide. The M.O.R.E. Institute promotes highly focused Regional, National and International Courses and Symposia on specific orthopedic topics. At Medacta USA, we understand that time and proximity can be major barriers to high quality orthopedic training and continuing medical education. Designed to meet orthopedic surgeons where they are, locally and in a socially distant environment, “M.O.R.E. on the MOVE” represents an effort to reinforce our commitment, coast to coast, by presenting enhanced opportunities in the pursuit of clinical excellence in total joint arthroplasty, spine and sports medicine.
| Where We’re Headed (the next stops...) | |
| Date | Location |
*dates and times subject to change
| Where We’ve Been | |
| Date | Location |
| January 29-30 | Battle Creek, MI |
| February 2-3 | Cleveland, OH |
| February 4 | Buffalo, NY |
| February 5 | Rochester, NY |
| February 6 | Albany, NY |
| February 11-13 | Philadelphia, PA |
| February 19-20 | Princeton, NJ |
| February 26-27 | Roanoke, VA |
| March 2-3 | Raleigh, NC |
| March 5-6 | Charlotte, NC |
| March 8-10 | Columbia, SC |
| March 12 | Reidsville, GA |
| March 13 | Savannah, GA |
| April 16-17 | Nashville, TN |
| April 23-24 | Little Rock, AR |
| April 30 - May 1 | Birmingham, AL |
| May 7-8 | New Orleans, LA |
| May 14-15 | Houston, TX |
| May 21-22 | Austin, TX |
| June 4-5 | Phoenix, AZ |
| June 14-15 | Loma Linda, CA |
Our motto, “The Surgeon is Never Alone”, has never been more apparent – especially in light of the ongoing challenges due to the COVID-19 pandemic. This mobile lab experience is being provided in partnership with the Surgical Training Institute. As potential exposure to COVID-19 is constant and unavoidable, it is important to provide clinical and temporal parameters for notification and protocol for staff isolations. In circumstances where STI or Medacta USA staff have a verified positive PCR COVID-19 test, STI & Medacta will be following the attached policy.
